Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Starts & Stops: Valve Repair And Replacement Tech Continues To Attract R&D Investment

Executive Summary

Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial announcements, initiations, completions, and suspensions each month. This month's edition, covering the period between mid-July and mid-August, includes trials from the biggest medtech players, some start-ups, and companies of every size in between.

Advertisement

Related Content

Starts & Stops: Boston Scientific Launches New Lotus TAVR Trial, Medtronic Starts Study Of SynchroMed II Pain Pump
Senseonics Rolls Out Eversense Subcutaneous Continuous Glucose Monitor
LivaNova Finishes Feasibility Trial Of Transcatheter Mitral Valve, Anticipates 2020 CE Mark
Abbott Launches Feasibility Trial Of Tricuspid Version Of MitraClip
'Sutureless' Surgical Aortic Valves Gain Medicare Bonus Payments
Starts & Stops: Abbott And Boston Scientific Lead Big List Of Trial Announcements
M&A Analysis: Grail's Chinese Merger Wraps Up Busy May
Starts & Stops: Abbott's Inherited Products Add To Spike In Suspensions
Abbott's Robert Ford: Device Chief Looks Ahead After St. Jude Deal
Edwards To Pay Up To $690m For Cardioband-Maker Valtech

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT105378

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel